1. Introduction {#s0005}
===============

Diabetes mellitus is a chronic disease that appears at all ages and leads to many serious complications including cardiovascular diseases, stroke, kidney failure, blindness, and nerve damage ([@b0220]). Among diabetic types, type 2 is the most common in adults due to the impaired diet and exercise regimens. The type 2 diabetes may commence from a combination of factors including genetic predisposition, environment, and pancreatic beta-cell dysfunction ([@b0140]). In these patients, their body cannot efficiently use insulin - a hormone that regulates glucose uptake into the cells. Without a proper control, this process will progressively lead the body to chronic insulin resistance, hyperglycemia, fatigue, weight loss, and other severe consequences. In fact, therapeutic interventions were proposed tended to control those pathogenic factors. However, the most beneficial method is keeping blood glucose at normal levels after a meal ([@b0005]). In human, the initial ingested foods are diverse, and they are complicatedly digested by multiple hydrolytic enzymes. Among these, α-amylase and α-glucosidase play a vital role in the hydrolysis of polysaccharides to liberate more suitable glucose for absorption ([@b0080]). The earlier study indicated that the hyperglycemia in type 2 diabetes patients was attributed to starch and glucose metabolism by pancreatic α-amylase and intestinal α-glucosidase ([@b0025]). On the other consideration, trypsin, an important proteolytic enzyme, takes part in many metabolic processes of human. Previous studies proved that trypsin inhibition might attenuate protein digestibility ([@b0205]) and indirectly reduce blood glucose level by enhancing insulin absorption ([@b0170], [@b0190]). Recent researches also demonstrated that trypsin inhibitors could restrain food intake by promoting satiety impression and therefore, prevented several metabolic diseases as diabetes and obesity ([@b0175], [@b0135], [@b0210], [@b0060]). For those reasons, the discovery of new potent inhibitors from natural origins which can simultaneously inhibit the activities of α-amylase, α-glucosidase and trypsin are a potential approach for the control of risks from type 2 diabetes.

Momilactones A (MA) and B (MB) ([Fig. 1](#f0005){ref-type="fig"}) have been known as authoritative allelochemicals against several pathogens of crops ([@b0110], [@b0235], [@b0115], [@b0075], [@b0055], [@b0180], [@b0090]). In addition, MA and MB might have a certain role to support tolerance of rice to salinity and drought stresses ([@b0250], [@b0195]). MA and MB also exhibited several beneficially bioactivities including antioxidant ([@b0090]), cytotoxic ([@b0065]), antitumor ([@b0120]) and anticancer activities ([@b0100], [@b0185]). Of which, MB is commonly determined in lower quantity in rice plant parts but exerted greater biological activities than MA. Nevertheless, the isolation and purification of MA and MB, chiefly from rice husk, are not straightforward. Currently, very few laboratories in the world can successfully isolate and purify MA and MB. As a result, the commercial price of pure standards MA and MB is not affordable, and therefore, studies on biological activities of the two compounds has been limited. Hitherto, the antidiabetic property of MA and MB has not been fully studied.Fig. 1Chemical structures of momilactones A and B ([@b0200]).

On the other hand, rice is the staple food for more than half of the world population. Besides using white rice as a main food source owing to its well-known nutritional values, rice by-products have had an increasing interest from food processing industry and pharmaceutical fields ([@b0085], [@b0215]). Theoretically, paddy-field produces approximately 70% white rice, 20% husk and 10% bran ([@b0085]). The diabetes inhibitory potential of crude extracts from rice by-products was sorely investigated ([@b0255], [@b0260]). Among rice by-products, rice bran versus diabetes was the most thoroughly studied. In which, tocotrienol, γ-oryzanol, fiber and functional peptides including amino acid sequences and protein hydrolysates were prerequisite compounds that could combat diabetes ([@b0085], [@b0095], [@b0240], [@b0230], [@b0155], [@b0040]). However, the antidiabetic role of individual compounds in rice bran has been sporadically studied. Recently, although MA and MB have been reported to be α-amylase and α-glucosidase inhibitors and appeared in different rice plant parts including leaf, husk, root as well as refined rice grain ([@b0200]), the presence of MA and MB and their contribution to the antidiabetic property in rice bran has not been revealed yet. Thus, in this study, we at first documented and compared the diabetic inhibitory potential of MA and MB in rice bran and γ-oryzanol (an outstanding diabetes inhibitor in rice bran) through in vitro assays of pancreatic α-amylase and trypsin inhibitions. The protocol to integrate HPLC and LC-ESI-MS to identify and quantify MA and MB in rice bran was also described.

2. Materials and methods {#s0010}
========================

2.1. Reagents {#s0015}
-------------

The extraction and isolation solvents were purchased from Junsei Chemical Co., Ltd., Tokyo, Japan. Acetonitrile used for LC analyses was obtained from Fisher Scientific company, Hampton, NH, USA. Iodine solution, acarbose, and γ-oryzanol were procured from Fujifilm Wako Pure Chemical Corporation, Osaka, Japan. Silica gel, α-amylase from porcine pancreas (type VI-B), α-glucosidase from *Saccharomyces cerevisiae*, trypsin from porcine pancreas, soluble starch, *p*-nitrophenyl-α-D-glucopyranoside (pNPG), Nα-benzoyl-L-arginine 4-nitroanilide hydrochloride (BAPNA) and all buffer components were acquired from Sigma-Aldrich, St. Louis, MO, USA.

2.2. Collection and preparation of samples {#s0020}
------------------------------------------

Rice husk and rice bran of Koshihikari variety (Japonica subtype) were collected from rice mills allocated near Hiroshima University, Higashi-Hiroshima Campus, Japan in July 2017. After drying by sunlight for one week, samples were deliberately sifted and winnowed to remove impurities. The samples were then dried in an oven at 50 °C for 3 days and kept in a container for further extractions.

2.3. Extraction and isolation process of momilactones A and B from rice husk {#s0025}
----------------------------------------------------------------------------

Extraction and isolation procedures were described previously ([@b0200]). Briefly, from 7 kg of rice husks, 52 mg of MA and 44 mg MB were isolated by repeated column chromatography ([Fig. 2](#f0010){ref-type="fig"}). The identification and confirmation of MA and MB were conducted by high performance liquid chromatography (HPLC), thin-layer chromatography (TLC), and gas chromatography-mass spectrometry (GC-MS) techniques. The structures of MA and MB were re-confirmed by ^1^H and ^13^C nuclear magnetic resonance (NMR) analyses and compared with those in the previous research ([@b0165]). The purified MA and MB were used for biological activities and quantification of these compounds in rice bran.Fig. 2The extraction and isolation process of momilactones A and B.

2.4. Quantification and confirmation of MA and MB in rice bran by HPLC and LC-ESI-MS {#s0030}
------------------------------------------------------------------------------------

Rice bran (100 g) was extracted by 400 mL of MeOH for 1 week. After filtering, crude methanolic extract was obtained and mixed with an equal volume of hexane in a separatory funnel. After 2 h, the hexane layer with fatty compounds was removed, the methanol layer was filtered and kept in a fridge (4 °C) for 1 day. The methanol-soluble part was separated from crystallized sugars by another filtration and evaporated to yield a defatted bran extract (DBE) with the stock concentration of 100 mg/mL ([Fig. 3](#f0015){ref-type="fig"}). The HPLC analysis was done in a similar method as described previously ([@b0200]). The contents of MA and MB in rice bran were compared and calculated in consonance with the retention times (RT) and peak areas of the standards MA and MB with the samples.Fig. 3Preparation of rice bran for HPLC and LC-ESI-MS analyses.

The DBE sample was analyzed by LC-ESI-MS technique. The analytical system included an LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, CA, USA) equipped with a source of electrospray ionization (ESI). The column Waters Spherisorb ODS2 (10 µm, 250 mm × 4.6 mm i.d.) and mobile phase comprising of 0.1% trifluoroacetic acid in 70% acetonitrile were used in LC phase. The operation time was 30 min with a flow rate of 0.4 mL/min under the room temperature. ESI condition was set up as follows: ion spray voltage (4.5 kV), sheath gas flow rate (60 arb) and aux gas flow rate (20 arb). MS analysis was run by a positive Fourier transform mass spectrometer (FTMS) at a resolution of 60,000 with a scan range of *m*/*z* 100--1000. An amount of 10 µL of DBE sample (50 mg/mL) and standard momilactones (0.5 mg/mL) were separately injected to the system by an autosampler. The presence of MA and MB in DBE was confirmed by comparing their extracted ion chromatograms (EIC) and mass spectra with those of standard momilactones.

2.5. α-Amylase and α-glucosidase inhibition assays {#s0035}
--------------------------------------------------

A modified model of the starch-iodine method described by [@b0015] was used to assess the porcine pancreatic α-amylase (PPA) inhibition of momilactones A and B, DFE, and γ-oryzanol. Concisely, in each well of a microplate (U-shape, Greiner Bio-one, NC, USA), 20 µL of sample were pre-incubated with 20 µL of PPA solution (2 mg/mL in 20 mM phosphate buffer containing 6 mM sodium chloride, pH 6.9) at 37 °C for 10 min. The reaction was activated by pipetting 30 µL of soluble starch (0.5%). After 6 min of incubation, an aliquot of 20 µL of hydrochloric acid (1 M) were added to stop the reaction, followed by 100 µL of 0.25 mM iodine solution. The absorbance at 565 nm was read by a microplate reader (Multiskan^TM^ Microplate Spectrophotometer, Thermo Fisher Scientific, Osaka, Japan). The inhibition percentage of samples on PPA was calculated by the following formula:$$\% inhibition = (S - W)/(C - W) \times 100$$where S is the absorbance of reaction with presence of samples, C is the absorbance of reaction without enzyme, W is the absorbance of reaction without samples. Acarbose was used as a positive reference. The IC~50~ value was determined to exhibit 50% inhibitory capacity of reaction at a certain concentration.

The α-glucosidase inhibitory assay was conducted, adhered to the earlier described protocol ([@b0200]). In brief, 40 µL of samples including momilactones A and B, DBE, and γ-oryzanol which were two-times diluted by 0.1 M potassium phosphate buffer (pH 7), were incubated with 40 µL of α-glucosidase enzyme solution (0.5 U/mL in the buffer) at 25 °C. After 6 min, 20 µL of 5 mM pNPG substrate were added to inaugurate the reaction. The mixture was incubated for another 8 min and eventually terminated by adding 100 µL of 0.1 M Na~2~CO~3~. The absorbance was recorded at 405 nm by a microplate reader. The inhibition percentage was calculated by the following equation:$$\% inhibition = (B - A)/Bx100$$where A is absorbance of reaction with either MA or MB or positive controls (acarbose or quercetin) and B is absorbance of reaction with 50% methanol in buffer. IC~50~ value was obtained by the same way as above.

2.6. Trypsin inhibition assay {#s0040}
-----------------------------

The trypsin inhibition was assayed using an adapted protocol of method reported previously ([@b0035]). Initially, the stock solution of samples was diluted two times by 50 mM Tris buffer (containing 20 mM CaCl~2~, pH 8.2). In each test sample, 50 µL of trypsin and 100 µL of BAPNA substrate were added, followed by incubation at 37 °C for 12 min. Finally, the reaction was stopped by pipetting 25 µL of acetic acid 30% into the mixture. Then absorbance was measured at 410 nm by a microplate reader. The inhibition percentage was calculated by the formula (ii) and IC~50~ value was achieved by the same way as mentioned above. Positive controls were caffeic acid and tannic acid. Final concentrations of enzyme and BAPNA substrate in the reaction were 40 and 160 µg/mL, respectively.

2.7. Statistical analysis {#s0045}
-------------------------

Data were elaborated on the Minitab 16.0 software (Minitab Inc., State College, PA, USA). All analyses were in a complete randomization with three replications, and results were displayed as mean ± standard error (SE). Significant differences were determined by one-way ANOVA using Tukey's test at *p* \< 0.05.

3. Results {#s0050}
==========

3.1. Isolation and confirmation of momilactones A and B {#s0055}
-------------------------------------------------------

By using the repeated column chromatography, MA and MB were successfully isolated from rice husk extract. The confirmation of MA and MB by HPLC, TLC, GC-MS, and NMR was reported previously ([@b0165], [@b0010], [@b0200]). The results can be seen in supplementary data (Figs. A1--A3).

3.2. Inhibition of α-amylase, α-glucosidase and trypsin {#s0060}
-------------------------------------------------------

In the previous study, we reported the inhibitory effects of MA and MB on α-amylase and α-glucosidase from bacteria ([@b0200]). In the present research, we confirmed such activity on porcine pancreatic α-amylase (PPA) together with a comparison of inhibitory activities of momilactones, defatted bran extract, and a well-known diabetic inhibitor γ-oryzanol. Additionally, to the extent of our knowledge, this is the first study that investigates inhibitory activities of MA and MB on trypsin, the enzyme linked to both diabetes and obesity.

Data present means ± standard errors. Means within a column followed by different letters are significantly different at p \< 0.05 level. -: not calculated. MA: momilactone A; MB: momilactone B; DBE: defatted bran extract; GO: γ-oryzanol

As shown in [Table 1](#t0005){ref-type="table"}, both MA and MB obtained inhibitory activities against PPA (IC~50~ = 132.56 and 129.02 µg/mL, respectively) and α-glucosidase (IC~50~ = 991.95 and 612.03 µg/mL, respectively ([@b0200])). These effects were also relatively compared with the well-known commercial diabetic inhibitor (acarbose: IC~50~ = 80.26 µg/mL for α-amylase and 2549.00 µg/mL for α-glucosidase). By comparing the IC~50~ values, it might conclude that MA and MB are asymptotic with the antidiabetic level of acarbose. On the other hand, DBE performed an IC~50~ value of 779.03 µg/mL for PPA inhibition while γ-oryzanol showed a negligible activity which was recorded as 18.65% inhibition at a concentration of 4 mg/mL. However, in α-glucosidase assay, γ-oryzanol (IC~50~ = 17.54 mg/mL) evinced a higher inhibitory activity than DBE (16.65 mg/mL). To sum up, MA and MB remarkably exhibited stronger suppressive effects than γ-oryzanol and DBE on both PPA and α-glucosidase assays.Table 1IC~50~ values of pancreatic α-amylase and α-glucosidase inhibitory activities of momilactones A and B, defatted bran extract, and γ-oryzanol.SampleIC~50~ value of α-amylase inhibition (µg/mL)IC~50~ value of α-glucosidase inhibition (µg/mL)MA132.56 ± 0.51 b991.95 ± 0.96 bMB129.02 ± 0.09 b612.03 ± 0.39 aDBE779.03 ± 3.87 c16653.00 ± 59.00 eGO--1754.20 ± 6.38 cAcarbose80.26 ± 0.24 a2549.00 ± 5.15 d

The inhibitory effect of MA and MB on trypsin activity was delineated by IC~50~ value (µg/mL) in [Fig. 4](#f0020){ref-type="fig"}. In particular, trypsin inhibition of MA (921.55 µg/mL) was significantly lower than that of MB (884.03 µg/mL). Both MA and MB comparably exhibited the inhibitory level as two phenolic inhibitors tannic acid (75.66 µg/mL) and caffeic acid (7.31 mg/mL). Conspicuously, trypsin inhibitory activity of MA was 7.9-folds and of MB was 8.2-folds stronger than caffeic acid. Meanwhile, DBE showed a trivial inhibition of 11.94% at a concentration of 20 mg/mL. γ-oryzanol did not offer an inhibition on trypsin activity.Fig. 4Trypsin inhibitory effect of momilactones A and B. **MA**: momilactone A; **MB**: momilactone B; **TA**: tannic acid; **CA**: caffeic acid; Dissimilar letters indicate significant differences (p \< 0.05).

3.3. Contents of MA and MB in rice bran {#s0065}
---------------------------------------

Results of HPLC and LC-ESI-MS showed that MA and MB contents in rice bran can be reliably identified and quantified. By HPLC, MA and MB in bran were determined by comparing the similarity of retention time and peak areas between sample and standards ([Fig. A.4](#s0100){ref-type="sec"}). As shown in [Table 2](#t0010){ref-type="table"}, quantity of MA and MB in rice bran was similar to each other (6.65 and 6.24 µg/g dry weight, respectively). This is the first study so far to detect and quantify MA and MB contents in rice bran.Table 2Peak information of momilactones A and B detected in rice bran by HPLC.SamplePeak estimationRetention timeAreaDBE50 + Std (3:1)MB14.532,322,546MA17.733,138,205DBE50MB14.53291,048MA17.74164,757

DBE50 was defatted bran extract at 50 mg/mL; DBE50 + Std0.5 (3:1) was defatted bran extract (50 mg/mL) mixed with pure MA and MB (0.5 mg/mL) at ratio 3:1 (v/v)

LC-ESI-MS method was introduced to be able to confirm the presence of MA and MB in rice grain ([@b0200]). In this research, by integration of a specific extraction and LC-ESI-MS methods, we certified the existence of these bioactive compounds in rice bran extract ([Fig. 3](#f0015){ref-type="fig"}). The use of a positive FTMS mode and certain mass range scans resulted in an extracted ion chromatogram (EIC) of the sample which illustrated two major peaks. The retention time and fragmentation patterns from peaks of DBE sample were confirmed as MA (RT∼19.87, 315.196) and MB (RT∼15.98, 331.190) which were totally coincided with those of standards MA and MB ([Fig. A.5](#s0100){ref-type="sec"}). [Fig. 5](#f0030){ref-type="fig"} illustrates LC-ESI-MS results, which first confirms the presence of MA and MB in rice bran.Fig. 5Extracted ion chromatograms and mass spectra of momilactones A and B detected in rice bran.

4. Discussion {#s0070}
=============

Nowadays, the use of available antidiabetic drugs may bring undesirable and severe side effects ([@b0030]). The quest of new antidiabetic compounds is indispensable to overcome diabetic problems worldwide. Nonetheless, the isolation and identification of active compounds with either no or minimal adverse effects are greater challenges to biomedical and scientific researches. To date, compounds with diterpene lactone structure possessing antidiabetic property have been released intermittently. An exhaustive search of related literature brought only one result which was andrographolide, a diterpenoid lactone isolated from *Andrographis paniculata*, was potent for diabetic control ([@b0270], [@b0225], [@b0045]). Hence, MA and MB regarded as a new chemical class performing antidiabetic ability in this study should be attached more special importance.

MA and MB have been principally detected in rice husk ([@b0115], [@b0075], [@b0160], [@b0165]; [@b0010]), leaf ([@b0250], [@b0145]), root and root exudates ([@b0110], [@b0115]). The content of MA and MB varied among rice cultivars and growing stage ([@b0250], [@b0145]). This research highlighted the antidiabetic activity of pure MA and MB, detected and quantified the two compounds in rice bran. Among enzymatic assays, MA and MB presented the most remarkable inhibition on porcine pancreatic α-amylase activity (IC~50~ = 132.56 and 129.02 µg/mL for MA and MB, respectively) which were closely in line with the activity of the standard inhibitor acarbose (IC~50~ = 80.26 µg/mL). These inhibitory activities might stem from the presence of lactone ring in the structure of MA and MB, which was reported to play a potent role in anti-α-glucosidase activity ([@b0265]). Additionally, diterpenoid component was convinced to be involved in trypsin deduction ([@b0245], [@b0105], [@b0125]). Moreover, the appearance of hydroxyl group at C-3 in the diterpenoid part of MB might increase the antidiabetic competence as compared to MA ([@b0200]). The influence of number and position of the hydroxyl groups of natural compounds on α-glucosidase and trypsin activities was substantiated by earlier studies ([@b9000], [@b0265], [@b9005]). Among plant-derived compounds, the phenolic group was most intensively elaborated due to its abundance and availability. [@b9010] reported the α-glucosidase inhibitory activity of kaempferol and chlorogenic acid isolated from *Gynura medica* leaf with the IC~50~ value of higher than 2 mg/mL. In research on trypsin inhibition of phenolics from extracts of pears, lentils and cocoa beans by [@b0205], gallic acid and catechin were potential inhibitors with IC~50~ values of 4.8 and higher than 10 mg/mL, respectively. By comparing with results of the present study, we documented that MA and MB were noteworthy diabetes inhibitors in term of α-amylase, α-glucosidase, and trypsin inhibitions.

Although previous studies introduced several techniques to isolate and purify MA and MB ([@b0075]; [@b0050] [@b0165], [@b0065], [@b0070]), none of them proposed a detailed process that can be extensively applicable for isolation these diabetic inhibitors as our study. Furthermore, we successfully developed a simple method that helped precisely detect MA and MB in rice bran for the first time. Results from the advanced technique LC-ESI-MS were reliable ([Fig. 5](#f0030){ref-type="fig"}), nevertheless, the key of achievements might emanate from the sample processing ([Fig. 3](#f0015){ref-type="fig"}). Particularly, after withdrawing fatty and low polarity components by hexane, we proceeded with a sugar abolishment based on the crystallization of sugars at low temperature. Basically, momilactones are minor constituents in rice and the productivity of MA and MB isolation may be accelerated by various factors as UV-irradiation ([@b0050], [@b0130]), temperature and extracting solvents ([@b0165]). The rejection of compounds with high molecular weight or lower polarity may enhance the sensitivity in detecting MA and MB, which has not been mentioned in the earlier researches. Though contents of MA and MB quantified in rice bran were 6.65 and 6.24 µg/g dry weight, respectively, their individual activity on the suppression of hydrolytic enzymes linked to diabetes was considerable. Therefore, the contribution of MA and MB to the anti-diabetic capacities of rice bran should be further endorsed by in vivo models as well as clinical trials.

In addition, γ-oryzanol, a commercially-important bioactive phytochemical of rice bran, is a mixture of ferulic acid esters of triterpene alcohols and sterols, which possesses a wide spectrum of health-beneficial effects, including anticarginogenic, anti-inflammatory, antihyperlipidemic, antidiabetic, and neuroprotective ([@b0150]). Most of the evidence about antidiabetic effect of γ-oryzanol was from in vivo assays, but no in vitro study on inhibitions of the key enzymes linked to diabetes was investigated. This current study for the first time resolved this concern. Results from in vitro assays pointed out that the inhibitory effect of MA and MB on α-amylase, α-glucosidase and trypsin were more significantly potent than that of γ-oryzanol and defatted bran extract. As a result, along with quantification results, MA and MB can be considered as new members of diabetic inhibitors and might contribute an active role to the diabetes inhibition of rice bran. Trends in the use of rice bran as a source of anti-diabetes, therefore, have been more fortified by this study.

5. Conclusion {#s0075}
=============

By in vitro assays, for the first time, the present study manifested the decisive function of MA and MB in the inhibition of key enzymes related to diabetes. The first identification and quantification of MA and MB in rice bran using advanced techniques may launch a new direction for further isolations of these diabetic inhibitors in larger scales. Findings of this research highlighted that MA and MB contributed an important role in anti-diabetes property of rice bran, although in vivo trials on MA and MB should be further explored. Given that quantities of MA and MB are largely varied among rice cultivars, the breeding of new rice cultivars with high amounts of MA and MB may be useful and economical to help control diabetes.

Appendix A. Supplementary material {#s0100}
==================================

The following are the Supplementary data to this article:Supplementary data 1
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